Home |
Free Dividend Report |
Stock Splits Calendar |
PLX Historical Stock Prices |
Preferred Stock Newsletter |
PLX Options Chain |
PLX Message Board |
Protalix BioTherapeutics (PLX) has the following price history information. Looking back at PLX historical stock prices for the last five trading days, on March 21, 2024, PLX opened at $1.37, traded as high as $1.37 and as low as $1.30, and closed at $1.32. Trading volume was a total of 294.70K shares. On March 22, 2024, PLX opened at $1.32, traded as high as $1.32 and as low as $1.26, and closed at $1.27. Trading volume was a total of 249.20K shares. On March 25, 2024, PLX opened at $1.27, traded as high as $1.31 and as low as $1.21, and closed at $1.22. Trading volume was a total of 707.50K shares. On March 26, 2024, PLX opened at $1.23, traded as high as $1.25 and as low as $1.22, and closed at $1.22. Trading volume was a total of 366.10K shares. On March 27, 2024, PLX opened at $1.22, traded as high as $1.28 and as low as $1.22, and closed at $1.25. Trading volume was a total of 378.20K shares.
PLX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Protalix BioTherapeutics shares, starting with a $10,000 purchase of PLX, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 03/31/2014 | |
End date: | 03/27/2024 | |
Start price/share: | $45.80 | |
End price/share: | $1.25 | |
Dividends collected/share: | $0.00 | |
Total return: | -97.27% | |
Average Annual Total Return: | -30.25% | |
Starting investment: | $10,000.00 | |
Ending investment: | $272.82 | |
Years: | 10.00 |
PLX Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
03/21/2024 | $1.37 | $1.37 | $1.30 | $1.32 | 294.70K |
03/22/2024 | $1.32 | $1.32 | $1.26 | $1.27 | 249.20K |
03/25/2024 | $1.27 | $1.31 | $1.21 | $1.22 | 707.50K |
03/26/2024 | $1.23 | $1.25 | $1.22 | $1.22 | 366.10K |
03/27/2024 | $1.22 | $1.28 | $1.22 | $1.25 | 378.20K |
About Protalix BioTherapeutics |
Protalix BioTherapeutics is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system. Co.'s proprietary ProCellEx platform is being used to manufacture its marketed product, Elelyso®, for the treatment of Gaucher disease. Co. is also developing, via ProCellEx, a pipeline of products. Co.'s clinical development program for pegunigalsidase alfa, or PRX-102, for the potential treatment of Fabry disease. In addition, Co. is developing uricase, or PRX-115, for the treatment of refractory gout. |
PLX Historical Closing Prices | |
Date | Close |
03/21/2024 | $1.32 |
03/22/2024 | $1.27 |
03/25/2024 | $1.22 |
03/26/2024 | $1.22 |
03/27/2024 | $1.25 |
Healthcare Historical Prices |
PLX is categorized under the Healthcare sector; below are some other companies in the same sector:
PLXP Historical Stock Prices
Free PLX Email Alerts:
|
PLX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.